Advair HFA (fluticasone propionate/salmeterol) Inhalation Aerosol, 45mcg/21 mcg 60 Actuations INST, NDC 0173-0715-22, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709.
Published December 5, 2012 · Recall initiated: October 24, 2012
Summary
FDA records drug Class III recall D-065-2013, published December 5, 2012 and initiated October 24, 2012. Recalling firm: GlaxoSmithKline, LLC.; Status: Terminated; Reported quantity: 18,676 Aerosol Units; Lot: 1ZP3065, Exp. Oct-12, 1ZP5453, Exp. Dec-12, 1ZP3315, Exp. May-13, 2ZP9974, Exp. Sep-13. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.
What to do
Voluntary: Firm initiated · Letter
Get an email if ADVAIR HFA has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ADVAIR HFA
- Manufacturer
- GlaxoSmithKline, LLC.
- Distributor
- Nationwide and Puerto Rico.
- Lot
- 1ZP3065, Exp. Oct-12, 1ZP5453, Exp. Dec-12, 1ZP3315, Exp. May-13, 2ZP9974, Exp. Sep-13.
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAdvair HFA (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol, 12g, 120 MeteredDecember 5, 2012
- FDAMylan, Tacrolimus Capsules 0.5 mg, 100 count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505December 5, 2012
- FDAReumofan Plus Tablets, 30-count bottle per Box, (remaining label information in Spanish)December 5, 2012
- FDAPradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by Boehringer IngelheimDecember 5, 2012
- FDAArranon (nelarabine) Injection 5mg/mL, 50mL Vials, Rx only, For I.V. Infusion only, GlaxoSmith Kline, ResearchDecember 5, 2012
- FDASenTec V-Sign Membrane Changer Insert (VS-MCI), 5 pieces. The SenTec V-Sign Membrane Changer Insert isNovember 28, 2012
Questions about this recall
Was Advair HFA (fluticasone propionate/salmeterol) Inhalation Aerosol, 45mcg/21 mcg 60 Actuations INST, NDC 0173-0715-22, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709. recalled?
Yes. FDA published recall D-065-2013 on December 5, 2012. Reported hazard: Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ADVAIR HFA.